LXLL.F Stock Overview
Eureka 93 Inc., a cannabidiol (CBD) life sciences company, engages in the research, development, extraction, production, processing, and distribution of CBD and other cannabinoids in the United States and Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Eureka 93 Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -99.00% |
5 Year Change | n/a |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
LXLL.F | US Personal Products | US Market | |
---|---|---|---|
7D | 0% | -0.8% | 0.6% |
1Y | n/a | -26.5% | 29.5% |
Return vs Industry: Insufficient data to determine how LXLL.F performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how LXLL.F performed against the US Market.
Price Volatility
LXLL.F volatility | |
---|---|
LXLL.F Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 10.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LXLL.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LXLL.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | Seann Poli | https://www.eureka93.com |
Eureka 93 Inc., a cannabidiol (CBD) life sciences company, engages in the research, development, extraction, production, processing, and distribution of CBD and other cannabinoids in the United States and Canada. The company offers hemp-derived CBD products, full plant extracts, and isolate powder. It is also involved in the development and manufacture of natural health products, as well as nutraceutical contract manufacturing business.
Eureka 93 Inc. Fundamentals Summary
LXLL.F fundamental statistics | |
---|---|
Market cap | US$74.00 |
Earnings (TTM) | -US$14.81m |
Revenue (TTM) | US$1.93m |
0.0x
P/S Ratio0.0x
P/E RatioIs LXLL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LXLL.F income statement (TTM) | |
---|---|
Revenue | US$1.93m |
Cost of Revenue | -US$6.01m |
Gross Profit | US$7.94m |
Other Expenses | US$22.75m |
Earnings | -US$14.81m |
Last Reported Earnings
Mar 31, 2019
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did LXLL.F perform over the long term?
See historical performance and comparison